Showing results (71-80 of 127) with videos related to
Sort By:
Pageof 13
Journal of Molecular Biology|August 2, 2001
Automated structure-based prediction of functional sites in proteins: applications to assessing the validity of inheriting protein function from homology in genome annotation and to protein dockingP Aloy, E Querol, F X Aviles, et al.Carcinogenesis|January 1, 1983
Molecular modelling studies on the non-covalent intercalative interactions between DNA and the enantiomers of anti-benzo[a]pyrene 7,8-diol-9,10-epoxideA Subbiah, S A Islam, S NeidleFaraday Discussions|January 1, 1992
Modelling the structure and function of enzymes by machine learningM J Sternberg, R A Lewis, R D King, et al.Protein Engineering|November 1, 1994
On the use of machine learning to identify topological rules in the packing of beta-strandsR D King, D A Clark, J Shirazi, et al.Nature|July 19, 1984
Structural and evolutionary analysis of HLA-D-region productsP Travers, T L Blundell, M J Sternberg, et al.FEBS Letters|December 19, 1988
Predictions of linear T-cell and B-cell epitopes in proteins encoded by HIV-1, HIV-2 and SIVMAC and the conservation of these sites between strainsM J Zvelebil, M J Sternberg, J Cookson, et al.Proceedings. International Conference on Intelligent Systems for Molecular Biology|January 1, 1994
Inductive logic programming used to discover topological constraints in protein structuresR D King, D A Clark, J Shirazi, et al.Journal of Molecular Biology|November 25, 1998
Conformational analysis of the first observed non-proline cis-peptide bond occurring within the complementarity determining region (CDR) of an antibodyP A Bates, P Dokurno, P S Freemont, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1992
Drug design by machine learning: the use of inductive logic programming to model the structure-activity relationships of trimethoprim analogues binding to dihydrofolate reductaseR D King, S Muggleton, R A Lewis, et al.Biochemical and Biophysical Research Communications|September 28, 1990
A molecular model for the enzyme cytochrome P450(17 alpha), a major target for the chemotherapy of prostatic cancerC A Laughton, S Neidle, M J Zvelebil, et al.Pageof 13